GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 184 filers reported holding GW PHARMACEUTICALS PLC in Q1 2017. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $56,308,000 | +82.4% | 259,600 | -3.0% | 0.00% | +100.0% |
| Q4 2020 | $30,875,000 | +9.1% | 267,525 | -8.0% | 0.00% | 0.0% |
| Q3 2020 | $28,295,000 | -52.9% | 290,654 | -40.6% | 0.00% | -50.0% |
| Q2 2020 | $60,080,000 | +62.0% | 489,570 | +15.6% | 0.00% | 0.0% |
| Q1 2020 | $37,080,000 | +30.5% | 423,431 | +55.8% | 0.00% | +100.0% |
| Q4 2019 | $28,413,000 | -15.3% | 271,739 | -6.8% | 0.00% | 0.0% |
| Q3 2019 | $33,530,000 | -58.3% | 291,493 | -37.5% | 0.00% | -66.7% |
| Q2 2019 | $80,386,000 | -10.1% | 466,300 | -12.1% | 0.00% | -25.0% |
| Q1 2019 | $89,379,000 | +67.2% | 530,224 | -3.4% | 0.00% | +33.3% |
| Q4 2018 | $53,466,000 | -45.6% | 548,995 | -3.5% | 0.00% | -25.0% |
| Q3 2018 | $98,252,000 | +8.8% | 568,787 | -12.1% | 0.00% | 0.0% |
| Q2 2018 | $90,272,000 | +3.5% | 646,928 | -16.4% | 0.00% | 0.0% |
| Q1 2018 | $87,210,000 | -14.7% | 774,033 | -0.1% | 0.00% | -20.0% |
| Q4 2017 | $102,243,000 | +21.3% | 774,508 | -6.7% | 0.01% | +25.0% |
| Q3 2017 | $84,288,000 | +67.1% | 830,508 | +65.0% | 0.00% | +33.3% |
| Q2 2017 | $50,448,000 | +31.2% | 503,218 | +58.3% | 0.00% | +50.0% |
| Q1 2017 | $38,447,000 | +1281466.7% | 317,901 | +1271504.0% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 25 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | +50.0% | 25 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 25 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | 0.0% | 25 | 0.0% | 0.00% | – |
| Q4 2015 | $2,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|